Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction

We read with great interest the article by Bosch et al. [(1)][1]. We congratulate the authors for their work, which sheds new light on the potential for preventing cardiotoxic effects of anticancer therapies. However, there are a few aspects that, in our opinion, need clarification. First,